
An ad campaign by Pancreatic Cancer Action has drawn criticism from other charities for ‘pitting’ different types of cancer against …

Celgene’s cancer drug Abraxane has been approved by European regulators to treat patients with metastatic adenocarcinoma of the pancreas, or …
Biotech company Amgen has abandoned its late-stage trial of a new drug for one of the most hard-to-treat of all …
A new cancer survival study shows that pancreatic cancer continues to have one of the worst mortality rates. The study …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

